This podcast is aimed at healthcare professionals, produced and funded by UCB.
In episode 1, our host, Prof Monika Arenbergerová, chats about updates in the most recent S2k clinical guidelines for hidradenitis suppurativa, with two of its co-authors: Dr Aikaterini Liakou and Dr Alejandro Molina Leyva. Together, they discuss changes in diagnosis, treatment recommendations, and their own personal experiences of putting the guidelines into practice.
Prof Monika Arenbergerová has received support from UCB, AbbVie, and Novartis.
Dr Aikaterini I. Liakou has received advisory board fees from Novartis and UCB and lecture honoraria and support for attending meetings from Amgen, AbbVie, Boehringer Ingelheim, Novartis and UCB Pharma. She is a sub-investigator in clinical trials of AbbVie, Boehringer Ingelheim, Insmed, Novartis, Sanofi and UCB.
Dr Alejandro Molina Leyva has received support for attending meetings, served as an advisory board member and participated in clinical trials for AbbVie, Novartis, MoonLake Immunotherapeutics, MSD, Sanofi, Incyte, Pfizer, Indero, Almirall and UCB.
","author_name":"UCB Biopharma"}